In contrast, the large China Stroke Primary Prevention Trial enrolled 20,000 patients with primary hypertension and known MTHFR C677T genotype and without history of myocardial infarction or stroke, clarifies the potential benefits of folic acid supplementation. Here, MTHFR is linked to stroke disorder.